Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induceangiogenesis (blood vessel generation inside the scaffold).

Biotechnology

Health Care

Spiderwort Inc.

Charles M. Cuerrier

Stephen Hanson

Scott Jarvis, Virtual CFO

Michelle Masson

Andrew Pelling

Research and Development

Leadership Team

Spiderwort Inc.

Org chart

Teams

Research and Development

Leadership Team

Similar companies